Document is current
Any future updates will be listed below
-
Authors
Karlas, Thomas https://orcid.org/0000-0002-8109-8526
Petroff, David
Feisthammel, Jürgen
Beer, Sebastian
Blüher, Matthias
Schütz, Tatjana
Lichtinghagen, Ralf
Hoffmeister, Albrecht
Wiegand, Johannes
-
Funding
Funding for this research was provided by:
Echosens
Siemens Healthineers
Universität Leipzig
- License Information
-
More Information
Article History
Received: 16 December 2021
Revised: 7 June 2022
Accepted: 7 June 2022
First Online: 17 June 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: Thomas Karlas and Johannes Wiegand received an unrestricted research grant from Echosens, France (not directly related to the project). Echosens provide calculations for CAP values from stored raw data.The ELF score analysis was supported by Siemens Healthcare Diagnostics, Eschborn, Germany (Johannes Wiegand and Ralf Lichtinghagen).Matthias Blüher received honoraria as a consultant and speaker from Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Lilly, Novo Nordisk, Novartis, and Sanofi (not related to the project).All other authors declare no conflict of interest.
